Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Lawrence W. Fitzgerald is active.

Publication


Featured researches published by Lawrence W. Fitzgerald.


Brain Research | 1991

Side and region dependent changes in dopamine activation with various durations of restraint stress

Jeffrey N. Carlson; Lawrence W. Fitzgerald; Richard W. Keller; Stanley D. Glick

Exposure to various mild stressors has been shown to result in the activation of dopamine containing neuronal systems projecting to the medial prefrontal cortex (PFC), to a lesser extent the nucleus accumbens septi/olfactory tubercle (NAS) and, in a few studies, the striatum. It has also been shown that dopamine (DA) systems on different sides of the PFC are successively activated as stressors are prolonged. We have therefore examined the effects of variation in the duration of a restraint stressor (15, 30 and 60 min) on region and side dependent alterations in DA utilization in the PFC, NAS and striatum. Increases in the concentrations of the DA metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and/or homovanillic acid (HVA) or in their ratios with DA were seen in all regions examined with the largest effects occurring in the PFC and lesser effects in the NAS and striatum. In each region, the magnitude of these effects varied with time of restraint exposure. In the PFC, lateralized alterations in HVA and DA were seen over time with effects progressing from a left greater than right involvement at 15 min to a right greater than left involvement at 60 min. These results are discussed with reference to side and region dependent effects on brain DA systems as stressors are prolonged and the implications they may have for lateralized regional brain activity associated with stressor precipitated psychiatric disease.


Journal of Medicinal Chemistry | 2009

Synthesis and structure-activity relationships of 8-(pyrid-3-yl)pyrazolo[1,5-a]-1,3,5-triazines: potent, orally bioavailable corticotropin releasing factor receptor-1 (CRF1) antagonists.

Paul J. Gilligan; Todd Clarke; Liqi He; Snjezana Lelas; Yu-Wen Li; Karen Heman; Lawrence W. Fitzgerald; Keith W. Miller; Ge Zhang; Anne Marshall; Carol M. Krause; John F. McElroy; Kathyrn Ward; Kim Zeller; Harvey Wong; Steven Bai; Joanne Saye; Scott J. Grossman; Robert Zaczek; Stephen P. Arneric; Paul R. Hartig; David Robertson; George L. Trainor

This report describes the syntheses and structure-activity relationships of 8-(substituted pyridyl)pyrazolo[1,5-a]-1,3,5-triazine corticotropin releasing factor receptor-1 (CRF(1)) receptor antagonists. These CRF(1) receptor antagonists may be potential anxiolytic or antidepressant drugs. This research resulted in the discovery of compound 13-15, which is a potent, selective CRF(1) antagonist (hCRF(1) IC(50) = 6.1 +/- 0.6 nM) with weak affinity for the CRF-binding protein and biogenic amine receptors. This compound also has a good pharmacokinetic profile in dogs. Analogue 13-15 is orally effective in two rat models of anxiety: the defensive withdrawal (situational anxiety) model and the elevated plus maze test. Analogue 13-15 has been advanced to clinical trials.


Journal of Neurochemistry | 1990

Serotonin metabolism by monoamine oxidase in rat primary astrocyte cultures

Lawrence W. Fitzgerald; Lynne Kaplinsky; Harold K. Kimelberg

Abstract: The oxidative deamination of serotonin (5‐HT) to 5‐hydroxyindoleacetic acid (5‐HIAA) by rat primary astrocyte cultures was investigated in intact cells using HPLC. All detectable 5‐HIAA accumulated in the extracellular medium, and its rate of production was proportional to the 5‐HT concentration over the tested range of 5 ± 10−7 to 10−4M. At 5 ± 10−7M 5‐HT, intracellular 5‐HT was detectable only in astrocytes treated with monoamine oxidase (MAO) inhibitors. These findings are consistent with the idea that 5‐HT taken up into astrocytes is not stored for re‐release, but is rapidly metabolized to 5‐HIAA, which is then extruded from the cell. At 5 ± 10−7M 5‐HT, 5‐HIAA formation in intact cells was blocked 63% by the selective high‐affinity 5‐HT uptake inhibitor fluoxetine. 5‐HT oxidation to 5‐HIAA is carried out principally by MAO‐A, because clorgyline was more effective at inhibiting the production of 5‐HIAA than was pargyline. Radioenzymatic determinations of MAO activity in cell homogenates supported these findings, because under these conditions clorgyline was 1,000‐fold more effective than pargyline at inhibiting MAO activity toward 14C‐labelled 5‐HT. However, the relatively selective MAO‐B substrate β‐phenylethylamine (PEA) was also oxidized, showing that these cultures also contained MAO‐B activity; the Km values for MAO‐A oxidation of 5‐HT and MAO‐B oxidation of PEA were 135 and 45 μM, and Vmax values were 88 and 91 nmol/mg of total cell protein/h, respectively. Higher concentrations of PEA (>20 γM) were oxidized by both MAO‐A and MAO‐B isozymes. These data support the idea that astrocytes in situ might take up 5‐HT and metabolize it to 5‐HIAA using the MAO‐A isozyme. However, sufficient activity of the MAO‐B isozyme appears to be present in astrocytes for metabolism of amines which also show MAO‐B selectivity.


Molecular Brain Research | 1990

Circling behavior exhibited by a transgenic insertional mutant

Anil K. Ratty; Lawrence W. Fitzgerald; Milt Titeler; Stanley D. Glick; John J. Mullins

We report here of an abnormal circling behavior expressed in the TgX15 transgenic mouse line as a result of insertional mutagenesis. Homozygous transgenic mice expressed the phenotype while heterozygous transgenics were normal. We also found that the dopamine D2 receptor binding sites in the striata of the circling mice were significantly elevated by about 31% compared to normal heterozygous transgenic mice. Other transgenic lines constructed with the same transgene appeared normal suggesting that, in the TgX15 line, a genetic locus significant in mammalian motor behavior has been disrupted.


Brain Research | 1993

Specificity of behavioral and neurochemical dysfunction in the chakragati mouse: a novel genetic model of a movement disorder

Lawrence W. Fitzgerald; Anil K. Ratty; Milt Teitler; Kenneth W. Gross; Stanley D. Glick

The chakragati (ckr) mouse is a transgenic insertional mutant that displays lateralized circling behavior, locomotor hyperactivity, hyperexcitability as well as body weight deficits. The mutation is autosomal and recessive. We have previously found that ckr mice have bilateral asymmetric elevations in striatal dopamine (DA) D2-like (D2, D3 and/or D4), but not D1-like (D1 and/or D5) receptors. Predictably, these mice increase turning in response to the D2-like agonist quinpirole and spontaneously rotate contralateral to the striatal side with the higher D2-like receptors. The overall objective of the present study was to assess the neurochemical specificity of the mutation in ckr mouse, particularly since motor behaviors can be elicited by a multitude of brain regions and neurotransmitter systems within the basal ganglia. Using quantitative receptor autoradiography, we examined the regional distribution of DA uptake sites and 5-HT1A, 5-HT1B/1D, GABAA and mu opioid receptors. Also, we wanted to determine whether increased behavioral laterality as seen in rotation is evident with another test of laterality, such as lateral paw preference. The ckr mice showed greater paw preferences than normal mice; however, neither the degree nor direction of these preferences correlated with rotational behavior. The ckr mice showed moderate decreases in the density of DA uptake sites in all subregions of the striatum, but not in the nucleus accumbens or olfactory tubercle. Interestingly, these decreases in ckr mice were not accompanied by a reduction in striatal tissue DA content. 5-HT1 and mu opiate receptor populations were normal in ckr mice. However, GABAA sites in the mediodorsal thalamus and superior colliculus were bilaterally and asymmetrically elevated in ckr mice. These data are consistent with the idea that the motor phenotypes of the ckr mouse result from specific disturbances within nigro-striatal, striato-pallido-thalamic and striato-nigro-collicular circuitry. The implications of these and past findings are discussed in relation to current thinking about hyperkinetic motor syndromes in humans involving reduced basal ganglia outflow.


Journal of Medicinal Chemistry | 2009

8-(4-Methoxyphenyl)pyrazolo[1,5-a]-1,3,5-triazines: Selective and Centrally Active Corticotropin-Releasing Factor Receptor-1 (CRF1) Antagonists

Paul J. Gilligan; Liqi He; Todd Clarke; Parcharee Tivitmahaisoon; Snjezana Lelas; Yu-Wen Li; Karen Heman; Lawrence W. Fitzgerald; Keith W. Miller; Ge Zhang; Anne Marshall; Carol M. Krause; John F. McElroy; Kathyrn Ward; Helen Shen; Harvey Wong; Scott J. Grossman; Gregory Nemeth; Robert Zaczek; Stephen P. Arneric; Paul R. Hartig; David W. Robertson; George L. Trainor

This report describes the syntheses and structure-activity relationships of 8-(4-methoxyphenyl)pyrazolo[1,5-a]-1,3,5-triazine corticotropin releasing factor receptor-1 (CRF(1)) receptor antagonists. CRF(1) receptor antagonists may be potential anxiolytic or antidepressant drugs. This research culminated in the discovery of analogue 12-3, which is a potent, selective CRF(1) antagonist (hCRF(1) IC(50) = 4.7 +/- 2.0 nM) with weak affinity for the CRF-binding protein and biogenic amine receptors. This compound also has a good pharmacokinetic profile in dogs. Analogue 12-3 is orally effective in two rat models of anxiety: the defensive withdrawal (situational anxiety) model and the elevated plus maze test. Analogue 12-3 has been advanced to clinical trials.


Brain Research | 1992

Asymmetric elevation of striatal dopamine D2 receptors in the chakragati mouse: neurobehavioral dysfunction in a transgenic insertional mutant

Lawrence W. Fitzgerald; Keith J. Miller; Anil K. Ratty; Stanley D. Glick; Milt Teitler; Kenneth W. Gross

We have previously reported the discovery of a transgenic insertional mutant, recently named the chakragati (ckr) mouse, which displays lateralized circling, locomotor hyperactivity, hyperreactivity, as well as body weight deficits. Since lateralized dopamine function is associated with circling behavior we sought to determine whether dopamine (DA) D1 and D2 receptors were asymmetrically distributed in the striata of adolescent and adult ckr mice using receptor autoradiography. Stereotypic and rotational responses to quinpirole served as behavioral indices of D2 receptor function. The ckr mice showed hemispherically asymmetric elevations in DA D2 receptors in the lateral subregions of the striatum whereas medial regions of the striatum were symmetrically and bilaterally elevated (overall elevation = 30%). As a group, ckr mice had higher D2 receptor levels on the side which was contralateral to the preferred direction of spontaneous nocturnal rotation. Striatal D1 receptors and mesolimbic D2 and D1 receptors of ckr mice were neither elevated nor differentially asymmetric. Young adult ckr mice showed dose-dependent increases in net rotations in response to quinpirole whereas normal mice showed no change from baseline levels. Both groups showed similar stereotypic responses. Older adult ckr mice, however, showed dose-dependent reductions in rotation after quinpirole whereas normal mice turned at baseline levels. Older ckr mice also displayed significantly greater stereotyped sniffing behavior. This unique mutant provides a novel genetic model of basal ganglia dysfunction, and may be useful in studying aspects of neuropsychiatric disorders associated with dopaminergic abnormalities.


Behavioral Neuroscience | 1991

Ontogeny of hyperactivity and circling behavior in a transgenic insertional mutant mouse

Lawrence W. Fitzgerald; Anil K. Ratty; Keith J. Miller; Mary K. Ellsworth; Stanley D. Glick; Kenneth W. Gross

In a previous study (Ratty et al., 1990), the discovery of a transgenic mutant mouse that displayed abnormal circling behavior was reported. Mice homozygous for the transgene display this phenotype, whereas heterozygotes are phenotypically normal. In this study, circling mutants displayed excessive lateralized circling behavior and locomotor hyperactivity by Postnatal Days (PND) 14 and 16, respectively. These abnormalities persisted unattenuated through adolescence and adulthood. Disturbances in rearing and grooming were also observed in circling mutants. Surface-righting ability in the mutants was normal, and the age of eye opening was only marginally delayed. However, body weights of the mutants were reduced compared with normal mice from PND 15 to adulthood. Possible relationships between the behaviors that are exhibited by circling mutants and previous neurochemical findings are discussed.


Physiology & Behavior | 1990

Right-sided population bias in male rats: Role of stress

Lawrence W. Fitzgerald; Stanley D. Glick; Jeffrey N. Carlson

Recent studies have shown that rats develop a pronounced right-sided population bias when tested repeatedly over several days in a shock-escape T-maze paradigm. In the present study we sought to determine if this bias was the result of learning or of the repeated exposure to a stressor (footshock). Rats were tested in the T-maze for 5 trials on each of 6 consecutive days. One group of rats (HS-C) was allowed a free left or right choice on each trial whereas another group of rats (HS-A) was forced to alternate left and right turns on each trial for the first 5 days of testing and then allowed a free choice on Day 6. The population and individual laterality of the HS-A group did not differ from that of the HS-C group, indicating that learning does not account for the biases. A third group of rats (LS-C) was tested using a lower shock level; this decrease in stressor intensity delayed the development of a right-sided population bias without affecting the development of individual laterality. These results indicate that repeated exposure to a stressor, rather than learning, is primarily responsible for the marked right-sided population bias observed in the T-maze.


Archive | 1995

Transgenic mouse as model for diseases involving dopaminergic dysfunction

Anil K. Ratty; Stanley D. Glick; John J. Mullins; Lawrence W. Fitzgerald; Kenneth W. Gross

Collaboration


Dive into the Lawrence W. Fitzgerald's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anil K. Ratty

Roswell Park Cancer Institute

View shared research outputs
Top Co-Authors

Avatar

Kenneth W. Gross

Roswell Park Cancer Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ge Zhang

Bristol-Myers Squibb

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge